Short Interest in Arcadia Biosciences Inc (NASDAQ:RKDA) Declines By 62.0%
Arcadia Biosciences Inc (NASDAQ:RKDA) saw a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 56,300 shares, a decrease of 62.0% from the May 30th total of 148,300 shares. Currently, 1.8% of the company’s shares are sold short. Based on an average daily trading volume, of 118,500 shares, the days-to-cover ratio is presently 0.5 days.
A number of research analysts have commented on RKDA shares. National Securities reaffirmed a “buy” rating and issued a $35.00 target price on shares of Calyxt in a research report on Thursday, May 9th. HC Wainwright upped their target price on shares of La Jolla Pharmaceutical from $25.00 to $27.00 and gave the company a “positive” rating in a research report on Thursday, June 6th.
NASDAQ RKDA traded up $0.17 during trading hours on Thursday, reaching $3.22. The company had a trading volume of 164,976 shares, compared to its average volume of 489,239. The firm has a 50-day moving average price of $4.09. Arcadia Biosciences has a 1-year low of $2.64 and a 1-year high of $10.40. The company has a debt-to-equity ratio of 2.80, a current ratio of 6.26 and a quick ratio of 6.19. The company has a market capitalization of $15.36 million, a PE ratio of -0.60 and a beta of -1.99.
About Arcadia Biosciences
Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.
Further Reading: QQQ ETF
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.